Click here for slides on this topic


Evolocumab

An injectable monoclonal antibody of the PCSK9 inhibitor class for the treatment of an inherited form of dyslipidemia called familial hypercholesterolemia (FH). Marketed as Repatha®.
The following content matched the glossary term: Evolocumab


Slide Library Results

Search Results for: Evolocumab Slides Found: 7
GAUSS-3 Evolocumab Reduces LDL-C in Statin-Intolerant Patients | NDEI
GAUSS-3 Absolute LDL-C Reduction With Evolocumab Statin Intolerance | NDEI
GAUSS-3: LDL-C Goal Achievement With Evolocumab Statin Intolerance | NDEI
GAUSS-3 Evolocumab Effects on Lipoproteins in Statin-Intolerant Patients | NDEI
GAUSS-3 Evolocumab Use in Statin-Intolerant Patients Muscle Symptoms | NDEI
GAUSS-3 Muscle-Related Adverse Events With Evolocumab & Ezetimibe | NDEI
GAUSS-3 Design Evolocumab Vs Ezetimibe in Statin Intolerance | NDEI